The use of metformin, a common regulator of blood glucose for diabetics, does not help protect against heart failure in non-diabetic patients who have suffered a heart attack, according to ...

In an ambulatory cohort of patients with diabetes and heart failure, this study found that metformin use was both safe and effective. After 2 years of follow-up, metformin therapy was associated ...

Metformin is safe for patients with advanced heart failure and diabetes mellitus, study shows Date: January 9, 2010 Source: University of California - Los Angeles ...

Metformin, a drug used to treat type 2 diabetes, is safe for use in treating patients who have both diabetes and advanced heart failure, U.S. researchers say.

Metformin may delay progression during early stages of heart failure, a retrospective observational study conducted in patients with left ventricular hypertrophy (LVH) presented at ACC.13, the ...

Patients with both heart failure and type 2 diabetes who are treated with a metformin-based strategy have a lower mortality risk than matched individuals not treated with anti-diabetic drugs, new ...

NASHVILLE, Tenn. — Even slight weight effects associated with metformin use may reduce risk for myocardial infarction and heart failure, according to a presenter here. “We don’t know how ...

Scientists at the University of Arizona have discovered that metformin, a drug commonly used to treat type 2 diabetes, might also be used to treat heart failure with preserved ejection fraction.

Older patients who were hospitalized for comorbid heart failure (HF) and diabetes had a lower risk for composite mortality and HF hospitalization when receiving metformin.

Historically, metformin has been avoided in patients with Type 2 diabetes and heart failure owing to the perceived increased risk of harm due to lactic acidosis.

A new study has shown that metformin, a drug often used in the treatment of diabetes mellitus, is safe for use in treating patients who have both diabetes and advanced heart failure. The study was ...

A study found that initiation of metformin is associated with improved 12-month clinical outcomes in patients with both heart failure and diabetes.